题名 | Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells |
作者 | |
发表日期 | 2024-08-29 |
发表期刊 | Journal of biomaterials science. Polymer edition 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Journal Article |
关键词 | Ovarian cancer cabazitaxel carmustine combination therapy liposomes |
其他关键词 | POLYMERIC NANOCARRIERS ; COMBINATION ; CHEMOTHERAPY ; RESISTANT ; THERAPY |
摘要 | Ovarian cancer is the primary cause of death from cancer in female patients. The existing treatments for ovarian cancer are restricted and ineffective in achieving a cure for the disease. To address this issue, we provide a novel approach to treating ovarian cancer by utilizing a liposomal carrier that effectively delivers the chemotherapeutic drugs carmustine (BCNU) and cabazitaxel (CTX). Initially, the combined impact of BCNU and CTX was confirmed, revealing that this impact reaches its maximum at a ratio of 1:2 mol/mol (BCNU/CTX). After that, the BC-Lipo co-delivery system was developed, which has a high capability for loading drugs (97.48% ± 1.14 for BCNU, 86.29% ± 3.03 for CTX). This system also has a sustained release profile and a beneficial long-circulating feature. The accumulation of BC-Lipo in tumors was dramatically enhanced compared to the accumulation of the free drug. Furthermore, BC-Lipo demonstrated similar levels of cytotoxicity to free BCNU and CTX (BCNU/CTX) when tested on HeLa cells in an in vitro model. Biochemical staining methods investigated the cancer cell's morphological examination. The apoptosis was confirmed by FITC-Annexin-V/PI staining by flow cytometry analysis. In addition, the investigation of fluorescence and protein markers examined the apoptosis mechanistic pathway, and the results indicated that BC-Lipo induced apoptosis due to mitochondrial membrane potential variation. This proof-of-concept study has established the probability of these BCNU-CTX combined treatments as active drug delivery nanocarriers for poorly soluble BCNU and CTX |
出版者 | TAYLOR & FRANCIS LTD |
ISSN | 0920-5063 |
EISSN | 1568-5624 |
DOI | 10.1080/09205063.2024.2387949 |
页数 | 21 |
WOS类目 | Engineering, Biomedical ; Materials Science, Biomaterials ; Polymer Science |
WOS研究方向 | Engineering ; Materials Science ; Polymer Science |
WOS记录号 | WOS:001300324700001 |
收录类别 | PUBMED ; SCIE ; EI |
EI入藏号 | 20243616986065 |
EI主题词 | Computerized tomography |
EI分类号 | 102.1.1 ; 102.1.2 ; 102.2.1 ; 103 ; 1106.5 ; 746 Imaging Techniques ; 941.2 Acoustic Variables Measurements |
URL | 查看原文 |
PubMed ID | 39207251 |
通讯作者地址 | [Gong, Jianming]3 Fuxue Xiang, Wenzhou 325000, Zhejiang, Peoples R China. |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/217687 |
专题 | 附属第一医院 第一临床医学院(信息与工程学院)、附属第一医院 第一临床医学院(信息与工程学院)、附属第一医院_妇产科学 |
作者单位 | Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. |
第一作者单位 | 附属第一医院; 妇产科学; 第一临床医学院(信息与工程学院)、附属第一医院 |
第一作者的第一单位 | 附属第一医院 |
推荐引用方式 GB/T 7714 | Jianming Gong,Renqian Feng,Xiaoqing Fu,et al. Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells[J]. Journal of biomaterials science. Polymer edition,2024. |
APA | Jianming Gong, Renqian Feng, Xiaoqing Fu, Qi Lin, & Bicheng Wu. (2024). Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells. Journal of biomaterials science. Polymer edition. |
MLA | Jianming Gong,et al."Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells".Journal of biomaterials science. Polymer edition (2024). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论